BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19811613)

  • 1. Pharmacological actions of curcumin in liver diseases or damage.
    Rivera-Espinoza Y; Muriel P
    Liver Int; 2009 Nov; 29(10):1457-66. PubMed ID: 19811613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress.
    Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Muriel P
    Fundam Clin Pharmacol; 2008 Aug; 22(4):417-27. PubMed ID: 18705752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
    Fu Y; Zheng S; Lin J; Ryerse J; Chen A
    Mol Pharmacol; 2008 Feb; 73(2):399-409. PubMed ID: 18006644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity.
    Shapiro H; Ashkenazi M; Weizman N; Shahmurov M; Aeed H; Bruck R
    J Gastroenterol Hepatol; 2006 Feb; 21(2):358-66. PubMed ID: 16509859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin-induced recovery from hepatic injury involves induction of apoptosis of activated hepatic stellate cells.
    Priya S; Sudhakaran PR
    Indian J Biochem Biophys; 2008 Oct; 45(5):317-25. PubMed ID: 19069843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat.
    Deters M; Klabunde T; Meyer H; Resch K; Kaever V
    Planta Med; 2003 Apr; 69(4):337-43. PubMed ID: 12709901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y; Ping J; Xu LM
    Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats.
    Sugiyama T; Nagata J; Yamagishi A; Endoh K; Saito M; Yamada K; Yamada S; Umegaki K
    Life Sci; 2006 Apr; 78(19):2188-93. PubMed ID: 16288784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
    Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
    Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer potential of curcumin: preclinical and clinical studies.
    Aggarwal BB; Kumar A; Bharti AC
    Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin: the Indian solid gold.
    Aggarwal BB; Sundaram C; Malani N; Ichikawa H
    Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and liver disease.
    Vera-Ramirez L; Pérez-Lopez P; Varela-Lopez A; Ramirez-Tortosa M; Battino M; Quiles JL
    Biofactors; 2013; 39(1):88-100. PubMed ID: 23303639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection.
    Wessler S; Muenzner P; Meyer TF; Naumann M
    Biol Chem; 2005 May; 386(5):481-90. PubMed ID: 15927892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
    López-Lázaro M
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
    Allam G
    Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curcumin in the treatment of prostatic diseases].
    Chen ZQ; Mo ZN
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):67-70. PubMed ID: 18297817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats.
    Xu Y; Ku B; Cui L; Li X; Barish PA; Foster TC; Ogle WO
    Brain Res; 2007 Aug; 1162():9-18. PubMed ID: 17617388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.